Madrigal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	9,707	13,226	6,730	4,568	5,179	1,449
Market Cap Growth	26.55%	96.52%	47.33%	-11.79%	257.45%	-15.74%
Enterprise Value	9,007	12,462	5,851	4,452	5,075	1,151
Last Close Price	435.62	582.34	308.57	231.38	290.25	84.74
PS Ratio	10.06	13.80	37.36	-	-	-
PB Ratio	16.51	21.95	8.92	11.27	26.24	7.39
P/TBV Ratio	16.20	22.22	8.98	11.27	26.24	7.39
EV/Sales Ratio	9.40	13.00	32.48	-	-	-
Debt / Equity Ratio	0.58	0.58	0.16	0.29	0.25	0.00
Net Debt / Equity Ratio	-1.05	-1.05	-1.07	-1.27	-1.56	-1.37
Net Debt / EBITDA Ratio	2.13	2.13	1.62	1.36	1.05	1.11
Net Debt / FCF Ratio	3.35	3.35	1.77	1.59	1.37	1.46
Asset Turnover	0.83	0.83	0.21	-	-	-
Inventory Turnover	1.03	1.03	-	-	-	-
Quick Ratio	3.60	3.60	5.79	5.35	3.10	3.52
Current Ratio	4.01	4.01	6.10	5.38	3.12	3.54
Return on Equity (ROE)	-42.49%	-42.49%	-80.35%	-123.98%	-150.12%	-110.92%
Return on Assets (ROA)	-16.30%	-16.30%	-36.98%	-47.41%	-57.71%	-54.09%
Return on Capital Employed (ROCE)	-31.60%	-31.60%	-57.00%	-72.90%	-119.00%	-123.40%
Earnings Yield	-2.99%	-2.18%	-6.92%	-8.18%	-5.70%	-16.69%
FCF Yield	-1.97%	-1.44%	-6.79%	-7.13%	-4.35%	-12.71%
Buyback Yield / Dilution	-5.46%	-5.46%	-13.83%	-9.05%	-3.64%	-7.05%

Updated Feb 19, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q